Trials / Unknown
UnknownNCT05298072
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (estimated)
- Sponsor
- University Hospital, Essen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aims to identify possible set of inflammatory biomarkers before, during and after anthracycline-based chemotherapy in breast cancer patients to identify (sub)clinical chemotherapy-related cardiac dysfunctionCRCD to identify patients who would benefit from additional cardioprotective therapy.
Conditions
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-04-01
- Completion
- 2023-12-01
- First posted
- 2022-03-28
- Last updated
- 2022-03-28
Source: ClinicalTrials.gov record NCT05298072. Inclusion in this directory is not an endorsement.